Topical treatments Various creams and suppositories are available to treat hemorrhoids, and many are available without a prescription
Heymsfields key contributions is his involvement in the discovery and development of GLP-1 receptor agonists, a class of drugs that have become a major breakthrough in obesity treatment
TG: OR: 1.44, 95%CI: 1.221.69, P = 1.84 10 5
[5] [6] Clinical trial data from the SURPASS and SURMOUNT studies demonstrate that gastrointestinal adverse eventsincluding nausea, diarrhea, vomiting, constipation, and abdominal discomfortoccur frequently with tirzepatide
However, based on patterns seen with tirzepatide and semaglutide, we can estimate that real-world retatrutide results will likely fall 3-5 percentage points below clinical trial averages
But it does add an important nuance: for patients taking GLP-1 medications to manage diabetes (rather than purely for weight loss), there may be a net benefit to gum health IF the other side effects (dry mouth, vomiting, nutritional gaps) are actively managed
.webp)
